Bicocca Open Archive

Logo unimib boa
CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 91.338
AS - Asia 49.292
EU - Europa 36.499
SA - Sud America 6.126
Continente sconosciuto - Info sul continente non disponibili 4.238
AF - Africa 1.025
OC - Oceania 205
AN - Antartide 1
Totale 188.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 86.396
SG - Singapore 16.178
IT - Italia 9.764
CN - Cina 9.703
VN - Vietnam 9.540
HK - Hong Kong 6.063
RU - Federazione Russa 5.129
DE - Germania 4.668
BR - Brasile 4.616
CA - Canada 4.062
SE - Svezia 3.562
IE - Irlanda 3.186
UA - Ucraina 2.622
GB - Regno Unito 1.962
FR - Francia 1.513
IN - India 1.402
BD - Bangladesh 1.178
KR - Corea 1.017
FI - Finlandia 974
ID - Indonesia 644
AT - Austria 611
TR - Turchia 560
AR - Argentina 553
NL - Olanda 506
JP - Giappone 495
IQ - Iraq 454
MX - Messico 372
ES - Italia 362
ZA - Sudafrica 320
PK - Pakistan 317
DK - Danimarca 284
PL - Polonia 283
LT - Lituania 244
SA - Arabia Saudita 227
PH - Filippine 221
EC - Ecuador 219
CO - Colombia 193
CH - Svizzera 178
BE - Belgio 177
VE - Venezuela 170
AU - Australia 169
MY - Malesia 153
UZ - Uzbekistan 145
EG - Egitto 132
MA - Marocco 117
CL - Cile 106
IR - Iran 103
TW - Taiwan 103
PY - Paraguay 95
JM - Giamaica 89
TN - Tunisia 89
JO - Giordania 88
CR - Costa Rica 85
KE - Kenya 85
AE - Emirati Arabi Uniti 80
ET - Etiopia 71
KZ - Kazakistan 71
PE - Perù 71
NP - Nepal 68
IL - Israele 67
TH - Thailandia 66
CZ - Repubblica Ceca 57
AZ - Azerbaigian 56
HN - Honduras 56
EU - Europa 54
RO - Romania 52
OM - Oman 50
UY - Uruguay 50
DZ - Algeria 49
PT - Portogallo 49
GT - Guatemala 44
GR - Grecia 43
AL - Albania 42
BO - Bolivia 41
TT - Trinidad e Tobago 38
NI - Nicaragua 34
DO - Repubblica Dominicana 32
LB - Libano 32
PA - Panama 32
KG - Kirghizistan 31
PS - Palestinian Territory 31
BG - Bulgaria 29
RS - Serbia 29
NZ - Nuova Zelanda 28
SV - El Salvador 28
HR - Croazia 25
BH - Bahrain 23
AO - Angola 21
NO - Norvegia 21
LY - Libia 20
HU - Ungheria 19
BB - Barbados 18
EE - Estonia 18
MD - Moldavia 18
GE - Georgia 17
NG - Nigeria 17
SY - Repubblica araba siriana 17
CI - Costa d'Avorio 16
KW - Kuwait 15
SN - Senegal 15
Totale 184.245
Salva come PNG Salva come JPEG
Città #
Ann Arbor 9.457
Singapore 9.408
Ashburn 8.075
Hong Kong 5.893
San Jose 5.224
Dallas 4.677
Woodbridge 4.650
Houston 3.598
Fairfield 3.564
Milan 3.205
Dublin 3.089
Ho Chi Minh City 2.905
Chandler 2.822
Toronto 2.809
Jacksonville 2.588
Frankfurt am Main 2.551
Wilmington 2.313
Hanoi 2.284
New York 1.971
Dearborn 1.768
Council Bluffs 1.767
Santa Clara 1.698
Seattle 1.498
Los Angeles 1.406
Beijing 1.362
Chicago 1.278
Princeton 1.262
Cambridge 1.193
The Dalles 1.051
Hefei 966
Boardman 842
Seoul 764
Nanjing 736
Rome 724
Lauterbourg 637
Shanghai 573
Buffalo 541
Vienna 493
Columbus 479
Hangzhou 471
Lawrence 467
Moscow 458
Altamura 451
São Paulo 436
Jakarta 419
Lachine 416
Helsinki 385
Guangzhou 334
Orem 305
Phoenix 294
Da Nang 291
Haiphong 287
Tokyo 278
Atlanta 270
Dong Ket 256
Munich 252
Brooklyn 228
San Diego 227
Nanchang 224
London 222
Montreal 222
Denver 212
Shenyang 210
Andover 207
Baghdad 197
Vilnius 197
Chennai 187
Biên Hòa 183
Warsaw 181
San Francisco 179
Ha Long 172
Hải Dương 170
Rio de Janeiro 170
Changsha 168
Nuremberg 165
Turin 165
Hebei 154
Tianjin 154
Boston 147
Johannesburg 142
Falls Church 137
Ottawa 131
Jinan 130
Tashkent 130
Naples 128
Manchester 126
Quận Bình Thạnh 125
Stockholm 125
Philadelphia 123
Fremont 122
Detroit 121
Washington 121
Brussels 120
Jiaxing 120
Can Tho 118
Pune 118
Zurich 118
Figino 116
Dhaka 115
Salt Lake City 114
Totale 115.132
Salva come PNG Salva come JPEG
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.184
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update 1.120
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 803
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 795
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 737
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy 674
CIPN and its mechanism of development 670
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 655
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 641
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 601
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 579
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 574
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 533
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 529
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 526
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 523
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients 521
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 516
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up 516
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 514
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 512
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 504
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 493
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 486
Malattie del Sistema Nervoso 479
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 476
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy 475
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 473
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 472
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 470
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 469
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 464
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 462
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 460
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 459
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 455
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 452
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 451
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 448
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 447
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 446
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 446
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy 445
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 444
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 440
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 439
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 437
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 435
Age-related changes in the function and structure of the peripheral sensory pathway in mice 434
Malattie del Sistema Nervoso 430
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 426
Enhanced brain targeting of engineered solid lipid nanoparticles 425
Exercise and Neuropathy: Systematic Review with Meta-Analysis 425
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 424
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials 423
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 422
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 422
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 419
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 409
A role for hemopexin in oligodendrocyte differentiation and myelin formation 408
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 408
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 402
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 401
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 394
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 394
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 392
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 389
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 387
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 381
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 381
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 379
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 379
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 377
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 374
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 373
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 370
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 370
Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients 370
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 369
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 366
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 365
The Italian multiple sclerosis register 365
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 365
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 362
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 357
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 356
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 354
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 353
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 351
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 347
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 346
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 346
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 346
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 345
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 344
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 344
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 343
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 342
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 341
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 340
Totale 45.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 583.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 583.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.328 0 0 0 674 494 679 356 401 350 500 563 1.311
2022/202312.587 1.556 3.514 1.176 1.070 883 1.959 170 655 891 141 313 259
2023/202410.535 333 388 446 421 1.434 2.356 1.952 439 784 247 246 1.489
2024/202525.396 1.580 2.865 1.747 1.196 2.151 927 1.382 972 2.935 3.296 2.230 4.115
2025/202670.090 9.620 5.692 7.286 5.626 6.128 3.522 8.829 3.162 5.066 5.392 4.902 4.865
2026/202716.733 3.621 3.972 7.181 1.959 0 0 0 0 0 0 0 0
Totale 188.724